VG9-39767-35127
2 vaccinations
4 coded responses
19 check-ins
0 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 0-4
- ZIP prefix
- 787 / TX
- Registered
- 2023-02-13
- Relationship
- Child or adolescent in my care
- Guardian
- 76R-55278-27813
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2023-02-13
Registered in v-safe
-
2023-02-13
Dose 1 — Pfizer-BioNTechCo-administered: Flu:Hepatitis B:Hib:Other:Rotavirus:Tetanus
-
2023-02-13
Health check-in — day 0, dose 1, under 3Feeling: Fair · Site: Swelling/hardness · Fever · SleepinessUnder 3 check-in
-
2023-02-15
Health check-in — days 1–6 daily, dose 1, under 3Feeling: Good · Sleepiness, Loss of appetiteUnder 3 check-in
-
2023-02-16
Health check-in — days 1–6 daily, dose 1, under 3Feeling: Good · Sleepiness, Loss of appetiteUnder 3 check-in
- 2023-02-17
- 2023-02-18
- 2023-02-19
-
2023-02-20
Survey response — day 7, dose 1, under 3MedDRA: Constipation — Feeling: GoodMedDRA releases: 2024-11
- 2023-02-27
-
2023-03-08
Survey response — day 21, dose 1, under 3MedDRA: Ear infection, Nasopharyngitis, Office visit — Feeling: Good · Be unable to work or attend school, Get care from a doctor or other healthcare professionalMedDRA releases: 2024-11
-
2023-03-08
Report sent to call center — day 21, dose 1, under 3Be unable to work or attend school · Get care from a doctor or other healthcare professional1 call case(s)
-
2023-03-09
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
-
2023-03-13
Dose 2 — Pfizer-BioNTechCo-administered: Flu
- 2023-03-13
-
2023-03-17
Health check-in — days 1–6 daily, dose 2, under 3Feeling: Good · Site: Redness · NoneUnder 3 check-in
- 2023-03-19
- 2023-03-20
-
2023-03-27
Survey response — day 14, dose 2, under 3MedDRA: Conjunctivitis, Ear infection, Office visit — Feeling: Fair · Be unable to work or attend school, Get care from a doctor or other healthcare professionalMedDRA releases: 2024-11
-
2023-03-27
Report sent to call center — day 14, dose 2, under 3Be unable to work or attend school · Get care from a doctor or other healthcare professional1 call case(s)
- 2023-03-28
- 2023-04-03
-
2023-04-10
Survey response — day 28, dose 2, under 3MedDRA: Abdominal pain upper, Vomiting — Feeling: FairMedDRA releases: 2024-11
- 2023-04-17
- 2023-04-24
- 2023-06-12
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2023-02-13 | Pfizer-BioNTech | Flu:Hepatitis B:Hib:Other:Rotavirus:Tetanus |
| 2 | 2023-03-13 | Pfizer-BioNTech | Flu |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2023-03-08 | Successful 2023-03-09 |
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill |
| 2023-03-27 | Unsuccessful |
Free text
None.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | · | · | ✓ |
| SD | Abdominal pain upper | · | · | ✓ |
| SD | Conjunctivitis | · | · | ✓ |
| SD | Ear infection | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Vomiting | · | · | ✓ |
| SRO | Constipation | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release